Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs.
Zhengye Biotechnology Holding stock last closed at $0.92, up 5.75% from the previous day, and has decreased 89.9% in one year. It has underperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.67 percentage points. Zhengye Biotechnology Holding stock is currently +35.29% from its 52-week low of $0.68, and -93.41% from its 52-week high of $13.97.
There are currently 47.39M shares of ZYBT outstanding. The market capitalization of ZYBT is $43.60M. In the last 24 hours, 61,600 ZYBT shares were traded.
You need an online brokerage account to access the NASDAQ market and buy ZYBT stock.
Based on our analysis, eToro is the best place to buy stocks. Here's why:
Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked the best brokerage, it's time to fill out some personal information so you can buy ZYBT today.
Now that you have finished signing up on investing apps, you need to deposit funds:
Check out the video below if you need help depositing money into your investment account.
After you have selected the best place to buy Zhengye Biotechnology Holding stock, it's important to analyze their stock prior to investing, so you truly comprehend the risk as well as the upside.
WallStreetZen was created to help average investors do better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on ZYBT's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ZYBT's fair value.
Using relative valuations ratios:
You can do additional valuation research on ZYBT's stock here.
Last year, ZYBT revenue was $17.06M. Over the past three year, ZYBT's revenue has grown by -82.3% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 6.34%.
Dig into ZYBT's earnings and revenue performance here.
In the past year, executives and large shareholders at ZYBT have not bought or sold any shares.
Research more about who owns ZYBT shares here.
No, Zhengye Biotechnology Holding doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
You have two primary order types:
Click the Open Trade button and eToro will execute the order.
If you want more help with investing in stocks on eToro, click the how to video below:
Now that you own some shares in ZYBT, you'll want to stay up-to-date on your new investment.
Put ZYBT on a watchlist to get notified of important updates regarding your ZYBT stock.
To reiterate, here are the 6 steps you need to take to buy Zhengye Biotechnology Holding stock right now:
If you require a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to monitor your investment in Zhengye Biotechnology Holding, hit the button below to create your watchlist.